There is an expectation that pharmaceutical companies should responsibly share the data that are generated by interventional clinical trials, and many pharmaceutical companies have committed to publishing all clinical trial data in peer-reviewed journals. In addition, timely publication of a manuscript in a ‘high-tier’ journal is a key goal for many clinical researchers.